Shares of Moderna jumped by a staggering 11.07% to $121.27 at 10:07 EST on Friday, following yesterday’s downward trend. The Nasdaq Stock Market is rising 0.48% to $12,094.40, after three successive sessions in a row of gains, on what up to now seems, a somewhat positive trend trading session today.
Moderna’s last close was $98.56, 11.61% under its 52-week high of $108.66.
Moderna’s sales growth is 1271.1% for the current quarter and 5174.8% for the next. The company’s growth estimates for the ongoing quarter is a negative 62.2% and positive 254.3% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s stock is valued at $121.27 at 10:07 EST, way above its 52-week high of $108.66.
Moderna’s value is way higher than its 50-day moving average of $77.77 and way higher than its 200-day moving average of $70.18.
According to Bloomberg Quint on Mon Nov 23, “Moderna Chief Sells More Shares Ahead of Urgent Vaccine Filing.”
According to Bloomberg Quint on Wed Nov 25, “Moderna Soars to Record Ahead of Final Covid Vaccine Analysis.”